Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAd951JsHkg4_4jOI_vRodPjHZ9_Ud_06lK1Zb8cgTRSc#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "halaven is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting 1 1 unresectable or metastatic liposarcoma who have received a prior anthracycline containing regimen 1 2 halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting see clinical studies 14 1 halaven is indicated for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline containing regimen see clinical studies 14 2" assertion.
- association object DOID_3382 assertion.
- association predicate treats assertion.
- association subject drugbank:DB08871 assertion.
- association relation TreatmentIndication assertion.
- drugbank:DB08871 category Drug assertion.
- DOID_3382 category Disease assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.